During the autumn, Calmark Sweden AB has been working to optimize the chemistry composition for two of its important biomarkers, LDH and glucose. The developement has proceeded according to plan and the new chemical components are ready for testing on filters in Calmark’s single-use items.
With this, all planned milestones for 2018, communicated in the prospectus, have been achieved.
“I am happy and proud of what we achieved in 2018. It is extremely gratifying that we succeed in keeping our ambitious schedule for the development project and I look forward to an exciting 2019 when everything is to be completed. Our plan is to launch the first products in 2020 and thus begin to receive revenue. I have great confidence that we will succeed in this.” CEO Anna Söderlund comments.